These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 11089384

  • 1. Anti-tumor potential of bisphosphonates.
    Green JR.
    Med Klin (Munich); 2000 Oct 15; 95 Suppl 2():23-8. PubMed ID: 11089384
    [Abstract] [Full Text] [Related]

  • 2. The antitumor potential of bisphosphonates.
    Clézardin P.
    Semin Oncol; 2002 Dec 15; 29(6 Suppl 21):33-42. PubMed ID: 12584693
    [Abstract] [Full Text] [Related]

  • 3. Antitumor effects of bisphosphonates.
    Green JR.
    Cancer; 2003 Feb 01; 97(3 Suppl):840-7. PubMed ID: 12548584
    [Abstract] [Full Text] [Related]

  • 4. Anti-tumour activity of zoledronic acid.
    Clézardin P.
    Cancer Treat Rev; 2005 Feb 01; 31 Suppl 3():1-8. PubMed ID: 16225995
    [Abstract] [Full Text] [Related]

  • 5. Preclinical pharmacology of zoledronic acid.
    Green JR.
    Semin Oncol; 2002 Dec 01; 29(6 Suppl 21):3-11. PubMed ID: 12584689
    [Abstract] [Full Text] [Related]

  • 6. Antitumor effects of bisphosphonates: promising preclinical evidence.
    Guise TA.
    Cancer Treat Rev; 2008 Dec 01; 34 Suppl 1():S19-24. PubMed ID: 18486348
    [Abstract] [Full Text] [Related]

  • 7. New results from the use of bisphosphonates in cancer patients.
    Coleman R, Gnant M.
    Curr Opin Support Palliat Care; 2009 Sep 01; 3(3):213-8. PubMed ID: 19561507
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Bisphosphonates in preclinical bone oncology.
    Clézardin P, Benzaïd I, Croucher PI.
    Bone; 2011 Jul 01; 49(1):66-70. PubMed ID: 21145441
    [Abstract] [Full Text] [Related]

  • 10. Bisphosphonates for the prevention of bone metastases.
    Coleman RE.
    Semin Oncol; 2002 Dec 01; 29(6 Suppl 21):43-9. PubMed ID: 12584694
    [Abstract] [Full Text] [Related]

  • 11. Clinical value of bisphosphonates in cancer therapy.
    Lüftner D, Henschke P, Possinger K.
    Anticancer Res; 2007 Dec 01; 27(4A):1759-68. PubMed ID: 17649770
    [Abstract] [Full Text] [Related]

  • 12. Differential inhibition of invasion and proliferation by bisphosphonates: anti-metastatic potential of Zoledronic acid in prostate cancer.
    Montague R, Hart CA, George NJ, Ramani VA, Brown MD, Clarke NW.
    Eur Urol; 2004 Sep 01; 46(3):389-401; discussion 401-2. PubMed ID: 15306113
    [Abstract] [Full Text] [Related]

  • 13. Skeletal complications of prostate cancer: pathophysiology and therapeutic potential of bisphosphonates.
    Green JR.
    Acta Oncol; 2005 Sep 01; 44(3):282-92. PubMed ID: 16076701
    [Abstract] [Full Text] [Related]

  • 14. The crossover of bisphosphonates to cancer therapy.
    Sun M, Iqbal J, Singh S, Sun L, Zaidi M.
    Ann N Y Acad Sci; 2010 Nov 01; 1211():107-12. PubMed ID: 21062299
    [Abstract] [Full Text] [Related]

  • 15. In vitro and in vivo antiresorptive effects of bisphosphonates in metastatic bone disease.
    Kanakis I, Kousidou OCh, Karamanos NK.
    In Vivo; 2005 Nov 01; 19(1):311-8. PubMed ID: 15796191
    [Abstract] [Full Text] [Related]

  • 16. The backbone of progress--preclinical studies and innovations with zoledronic acid.
    Green JR, Guenther A.
    Crit Rev Oncol Hematol; 2011 Feb 01; 77 Suppl 1():S3-S12. PubMed ID: 21353178
    [Abstract] [Full Text] [Related]

  • 17. Bisphosphonates induce apoptosis of stromal tumor cells in giant cell tumor of bone.
    Cheng YY, Huang L, Lee KM, Xu JK, Zheng MH, Kumta SM.
    Calcif Tissue Int; 2004 Jul 01; 75(1):71-7. PubMed ID: 15037971
    [Abstract] [Full Text] [Related]

  • 18. Bisphosphonates and cancer-induced bone disease: beyond their antiresorptive activity.
    Clézardin P, Ebetino FH, Fournier PG.
    Cancer Res; 2005 Jun 15; 65(12):4971-4. PubMed ID: 15958534
    [Abstract] [Full Text] [Related]

  • 19. Differential effect of doxorubicin and zoledronic acid on intraosseous versus extraosseous breast tumor growth in vivo.
    Ottewell PD, Deux B, Mönkkönen H, Cross S, Coleman RE, Clezardin P, Holen I.
    Clin Cancer Res; 2008 Jul 15; 14(14):4658-66. PubMed ID: 18628481
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.